Nuveen Asset Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 154,750 shares of VNDA stock, worth $773,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

154,750

Previous 526,823 70.63%

Holding current value

$773,750

Previous $2.98 Million 75.64%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.61 - $6.34 $1.72 Million - $2.36 Million	-372,073 Reduced 70.63%	154,750 $725,000
Q2 2024 Aug 09, 2024	BUY	$3.91 - $6.5 $876,516 - $1.46 Million	224,173 Added 74.07%	526,823 $2.98 Million
Q1 2024 May 13, 2024	BUY	$3.47 - $4.61 $513,213 - $681,819	147,900 Added 95.57%	302,650 $1.24 Million
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $4,853 - $6,576	1,436 Added 0.94%	154,750 $653,000
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $1.06 Million - $1.62 Million	-246,689 Reduced 61.67%	153,314 $662,000
Q2 2023 Aug 14, 2023	SELL	$5.9 - $6.95 $1.14 Million - $1.35 Million	-193,685 Reduced 32.62%	400,003 $2.64 Million
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $130,231 - $168,373	21,073 Added 3.68%	593,688 $4.03 Million
Q4 2022 Feb 14, 2023	SELL	$6.87 - $10.96 $3.48 Million - $5.55 Million	-506,276 Reduced 46.93%	572,615 $4.23 Million
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $860,040 - $1.07 Million	91,106 Added 9.22%	1,078,891 $10.7 Million
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $65,337 - $83,093	7,018 Added 0.72%	987,785 $10.8 Million
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $169,114 - $258,196	-15,601 Reduced 1.57%	980,767 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $2.69 Million - $3.63 Million	171,565 Added 20.8%	996,368 $15.6 Million
Q3 2021 Nov 12, 2021	BUY	$15.35 - $21.27 $9.03 Million - $12.5 Million	588,107 Added 248.47%	824,803 $14.1 Million
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $142,222 - $194,730	-9,053 Reduced 3.68%	236,696 $5.09 Million
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $85,740 - $129,568	-6,389 Reduced 2.53%	245,749 $3.69 Million
Q4 2020 Feb 16, 2021	BUY	$9.77 - $13.81 $5,764 - $8,147	590 Added 0.23%	252,138 $3.31 Million
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $213,390 - $275,209	-22,896 Reduced 8.34%	251,548 $2.43 Million
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $5.07 Million - $6.31 Million	-525,247 Reduced 65.68%	274,444 $3.14 Million
Q1 2020 May 14, 2020	SELL	$7.5 - $16.8 $1.65 Million - $3.7 Million	-220,168 Reduced 21.59%	799,691 $8.28 Million
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $1.79 Million - $2.52 Million	-144,247 Reduced 12.39%	1,019,859 $16.7 Million
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $2.63 Million - $3.38 Million	213,959 Added 22.52%	1,164,106 $15.5 Million
Q2 2019 Aug 15, 2019	BUY	$13.37 - $18.85 $12.7 Million - $17.9 Million	950,147 New	950,147 $13.4 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.3M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $283M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Vanda Pharmaceuticals Inc. Transaction History